CLINICAL TRIAL
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer
An abstract is available from the original source but is not redistributed by this tracker. Read the source record.